Genetic studies of chondrocalcinosis
- PMID: 15838246
- DOI: 10.1097/01.bor.0000157042.19740.f4
Genetic studies of chondrocalcinosis
Abstract
Purpose of review: Our understanding of the causation of the chondrocalcinosis and other disorders characterized by ectopic mineralization is rapidly increasing, and genetic studies have contributed substantially to recent major advances in the field. This review will discuss what is known about the genetics of chondrocalcinosis and what we have learned from genetic studies to date.
Recent findings: Chondrocalcinosis is one of a family of conditions associated with ectopic mineralization. This family also includes disorders of mineralization of bone and spinal and other ligaments, and vascular calcification. There has been increasing evidence of the key role of transport and metabolism of inorganic pyrophosphate (PPi) in control of mineralization, and as the likely explanation for the association of a variety of genetic variants with chondrocalcinosis and ectopic mineralization elsewhere. This may be an overly simplistic view of this family of conditions, with recent evidence suggesting that, for example, ANKH variants may not all predispose to chondrocalcinosis by effects on PPi transport, but may also influence chondrocyte maturation.
Summary: Understanding the control of the process of mineralization and its tissue specificity are important steps in the search for rational therapies for these conditions.
Similar articles
-
Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate.Arthritis Rheum. 2005 Apr;52(4):1110-7. doi: 10.1002/art.20978. Arthritis Rheum. 2005. PMID: 15818664
-
Calcium pyrophosphate deposition disease: a review of epidemiologic findings.Curr Opin Rheumatol. 2016 Mar;28(2):133-9. doi: 10.1097/BOR.0000000000000246. Curr Opin Rheumatol. 2016. PMID: 26626724 Review.
-
Genetics of chondrocalcinosis.Osteoarthritis Cartilage. 2005 Sep;13(9):745-50. doi: 10.1016/j.joca.2005.04.006. Osteoarthritis Cartilage. 2005. PMID: 15951203 Review.
-
Ankylosing spondylitis, late osteoarthritis, vascular calcification, chondrocalcinosis and pseudo gout: toward a possible drug therapy.Curr Med Chem. 2011;18(14):2196-203. doi: 10.2174/092986711795656153. Curr Med Chem. 2011. PMID: 21517761 Review.
-
The role of ANKH in pathologic mineralization of cartilage.Curr Opin Rheumatol. 2016 Mar;28(2):145-51. doi: 10.1097/BOR.0000000000000247. Curr Opin Rheumatol. 2016. PMID: 26599446 Review.
Cited by
-
Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold?Curr Rheumatol Rep. 2024 Oct;26(10):354-365. doi: 10.1007/s11926-024-01161-w. Epub 2024 Aug 1. Curr Rheumatol Rep. 2024. PMID: 39088093 Free PMC article. Review.
-
[Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].Z Rheumatol. 2007 Nov;66(7):573-4, 576-8. doi: 10.1007/s00393-007-0221-1. Z Rheumatol. 2007. PMID: 17932681 German.
-
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.Arthritis Res Ther. 2014 Oct 15;16(5):458. doi: 10.1186/s13075-014-0458-4. Arthritis Res Ther. 2014. PMID: 25315665 Free PMC article. Clinical Trial.
-
An Update on the Diagnosis and Management of Calcium Crystal Disease.Curr Rheumatol Rep. 2023 Aug;25(8):145-151. doi: 10.1007/s11926-023-01106-9. Epub 2023 May 30. Curr Rheumatol Rep. 2023. PMID: 37249830 Free PMC article. Review.
-
Extracellular pyrophosphate in the kidney: how does it get there and what does it do?Nephron Physiol. 2012;120(4):p33-8. doi: 10.1159/000341597. Epub 2012 Oct 12. Nephron Physiol. 2012. PMID: 23075758 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials